Aleksandra Wierzbicka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Aleksandra Wierzbicka has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
- Adam Wichniak
Third Department of Psychiatry, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland
21 shared publications Wojciech Jernajczyk
Sleep Disorders Center, Department of Clinical Neurophysiology, Institute of Psychiatry and Neurology in Warsaw, Warsaw, Poland
14 shared publications- Eva Feketeova
Department of Neurology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia
7 shared publications - Yves Dauvilliers
Institute of Neurosciences of Montpellier (INM), University of Montpellier, INSERM , Montpellier
7 shared publications Geert Mayer
Neurology Department, Hephata Klinik, Schwalmstadt, Germany
6 shared publicationsJohannes Mathis
Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland
6 shared publications
Latest Publications
- 11 November 2026
- Published by Wiley in Journal of Sleep Research
2010 and 2013 Incidence Peaks in Narcolepsy and Idiopathic Hypersomnia Linked to Type A H1N1 and Type B Victoria Influenza Strains
Increased narcolepsy type‐1 (NT1) incidence rates were reported globally in 2010, linked to the H1N1 2009–2010 influenza pandemic and Pandemrix vaccination. A child‐specific NT1 peak was observed in Europe in 2013, further raising questions about the relationship between NT1 and influenza infections. This study analysed annual European incidence patterns of central disorders of hypersomnolence (CDH) in relation to influenza severity. All NT1 ( N = 981) and a combined group of narcolepsy type‐2 (NT2) and idiopathic hypersomnia (IH) ( N = 545) cases from eight European centers were studied from 1995 to 2019. Linear mixed models and Spearman correlations were applied to investigate the relationships between CDH incidence and the severity of preceding influenza seasons, including H1N1, H3N2, and for the Netherlands, influenza Type B Victoria and Yamagata. Peaks in NT1 incidence were present in 2010 and 2013, while a 2010 child‐specific peak was identified in NT2 and IH. Both groups showed a significantly positive correlation with H1N1 influenza severity and a negative correlation with H3N2. NT1 was also significantly associated with influenza Type B Victoria in the Netherlands, particularly in children. These findings suggest that, beyond H1N1, influenza Type B Victoria may be a novel trigger for NT1. Similar to NT1, the 2010 children peak in NT2 and IH may indicate possible immune‐related pathophysiologies linked to the 2009–2010 H1N1 pandemic. Further immunological studies are warranted to unravel the complexities of these relationships and their implications for CDH.
- 11 November 2026
- Published by Wiley in Journal of Sleep Research
2010 and 2013 Incidence Peaks in Narcolepsy and Idiopathic Hypersomnia Linked to Type A H1N1 and Type B Victoria Influenza Strains
Increased narcolepsy type‐1 (NT1) incidence rates were reported globally in 2010, linked to the H1N1 2009–2010 influenza pandemic and Pandemrix vaccination. A child‐specific NT1 peak was observed in Europe in 2013, further raising questions about the relationship between NT1 and influenza infections. This study analysed annual European incidence patterns of central disorders of hypersomnolence (CDH) in relation to influenza severity. All NT1 ( N = 981) and a combined group of narcolepsy type‐2 (NT2) and idiopathic hypersomnia (IH) ( N = 545) cases from eight European centers were studied from 1995 to 2019. Linear mixed models and Spearman correlations were applied to investigate the relationships between CDH incidence and the severity of preceding influenza seasons, including H1N1, H3N2, and for the Netherlands, influenza Type B Victoria and Yamagata. Peaks in NT1 incidence were present in 2010 and 2013, while a 2010 child‐specific peak was identified in NT2 and IH. Both groups showed a significantly positive correlation with H1N1 influenza severity and a negative correlation with H3N2. NT1 was also significantly associated with influenza Type B Victoria in the Netherlands, particularly in children. These findings suggest that, beyond H1N1, influenza Type B Victoria may be a novel trigger for NT1. Similar to NT1, the 2010 children peak in NT2 and IH may indicate possible immune‐related pathophysiologies linked to the 2009–2010 H1N1 pandemic. Further immunological studies are warranted to unravel the complexities of these relationships and their implications for CDH.
- Open Access
- 6 May 2026
- Published by Elsevier in SSRN Electronic Journal
Tailoring Eu3+ luminescence nad local symmetry in Cd₁₋ₓMgₓO thin films via Mg alloying and annealing
In this work, Eu³⁺-doped Cd₁₋ₓMgₓO thin films were deposited on p-type Si substrates using plasma-assisted molecular beam epitaxy. The effects of Mg incorporation and post-growth annealing on the structural and optical properties were examined. X-ray diffraction revealed the polycrystalline character of the films, while energy-dispersive X-ray spectroscopy indicated a homogeneous distribution of the constituent elements within the experimental resolution. Cathodoluminescence measurements show that the emission is dominated by sharp intra-4f transitions of Eu³⁺ ions in the red spectral region, with no detectable contribution from the host matrix. This behavior suggests efficient excitation of Eu³⁺ centers, likely mediated by energy transfer from the Cd₁₋ₓMgₓO host. The emission intensity increases with Mg content, indicating a composition-dependent modification of the excitation and recombination processes. Spectral analysis of the ⁵D₀→⁷F₁ and ⁵D₀→⁷F₂ transitions suggests that Eu³⁺ ions are primarily located at sites with inversion symmetry, while annealing leads to a partial redistribution toward environments of reduced symmetry. Time-resolved measurements reveal that both Mg content and thermal treatment significantly affect the decay dynamics. For lower Mg concentrations, annealing results in a simplification of the decay behavior, consistent with a more homogeneous distribution of Eu³⁺ environments. In contrast, films with higher Mg content retain a multi-component decay, indicating persistent structural disorder and the presence of multiple recombination channels.
- 6 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessTailoring Eu3+ luminescence nad local symmetry in Cd₁₋ₓMgₓO thin films via Mg alloying and annealing
In this work, Eu³⁺-doped Cd₁₋ₓMgₓO thin films were deposited on p-type Si substrates using plasma-assisted molecular beam epitaxy. The effects of Mg incorporation and post-growth annealing on the structural and optical properties were examined. X-ray diffraction revealed the polycrystalline character of the films, while energy-dispersive X-ray spectroscopy indicated a homogeneous distribution of the constituent elements within the experimental resolution. Cathodoluminescence measurements show that the emission is dominated by sharp intra-4f transitions of Eu³⁺ ions in the red spectral region, with no detectable contribution from the host matrix. This behavior suggests efficient excitation of Eu³⁺ centers, likely mediated by energy transfer from the Cd₁₋ₓMgₓO host. The emission intensity increases with Mg content, indicating a composition-dependent modification of the excitation and recombination processes. Spectral analysis of the ⁵D₀→⁷F₁ and ⁵D₀→⁷F₂ transitions suggests that Eu³⁺ ions are primarily located at sites with inversion symmetry, while annealing leads to a partial redistribution toward environments of reduced symmetry. Time-resolved measurements reveal that both Mg content and thermal treatment significantly affect the decay dynamics. For lower Mg concentrations, annealing results in a simplification of the decay behavior, consistent with a more homogeneous distribution of Eu³⁺ environments. In contrast, films with higher Mg content retain a multi-component decay, indicating persistent structural disorder and the presence of multiple recombination channels.
- 3 April 2020
- Published by Wiley in Journal of Sleep Research
- Vol. 30 (1) , e13031
Sleep among primary care physicians–Association with overtime, night duties and strategies to counteract poor sleep quality
Physicians belong to the risk group for sleep disorders as a result of work related stress, excessive working time, large amount of on‐call duties and shift work. Poor sleep quality of healthcare providers threatens not only their safety, but also the safety of their patients. This study examines if there are any differences in how working either long hours or at night duties relates to self‐reported sleep time, sleep quality and daytime sleepiness in primary care physicians. We analyzed data from a survey research of 807 participants. Respondents were divided into four groups based on their reported work hours per week and number of nights on duty per month. Overtime was associated with shorter sleep time and worse subjective sleep quality even when compared with that of participants who work on night duties. All investigated groups of participants reported short sleep latencies which suggests that sleep debt is a common problem in this population. Surprisingly in the case of poor sleep quality participants rarely used recommended methods like regular physical activity or specialist advice. The most frequently reported answer was that they do nothing to improve sleep and every third participants uses hypnotics to do that. These results suggest that primary care physicians despite being at high risk for sleep disorders due to working overtime and at night, pay less attention to their sleep quality and do not use recommended strategies to improve it.
- 3 April 2020
- Published by Wiley in Journal of Sleep Research
- Vol. 30 (1) , e13031
Sleep among primary care physicians–Association with overtime, night duties and strategies to counteract poor sleep quality
Physicians belong to the risk group for sleep disorders as a result of work related stress, excessive working time, large amount of on‐call duties and shift work. Poor sleep quality of healthcare providers threatens not only their safety, but also the safety of their patients. This study examines if there are any differences in how working either long hours or at night duties relates to self‐reported sleep time, sleep quality and daytime sleepiness in primary care physicians. We analyzed data from a survey research of 807 participants. Respondents were divided into four groups based on their reported work hours per week and number of nights on duty per month. Overtime was associated with shorter sleep time and worse subjective sleep quality even when compared with that of participants who work on night duties. All investigated groups of participants reported short sleep latencies which suggests that sleep debt is a common problem in this population. Surprisingly in the case of poor sleep quality participants rarely used recommended methods like regular physical activity or specialist advice. The most frequently reported answer was that they do nothing to improve sleep and every third participants uses hypnotics to do that. These results suggest that primary care physicians despite being at high risk for sleep disorders due to working overtime and at night, pay less attention to their sleep quality and do not use recommended strategies to improve it.
- Open Access
- 13 July 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-11
Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning
Narcolepsy is a rare life-long disease that exists in two forms, narcolepsy type-1 (NT1) or type-2 (NT2), but only NT1 is accepted as clearly defined entity. Both types of narcolepsies belong to the group of central hypersomnias (CH), a spectrum of poorly defined diseases with excessive daytime sleepiness as a core feature. Due to the considerable overlap of symptoms and the rarity of the diseases, it is difficult to identify distinct phenotypes of CH. Machine learning (ML) can help to identify phenotypes as it learns to recognize clinical features invisible for humans. Here we apply ML to data from the huge European Narcolepsy Network (EU-NN) that contains hundreds of mixed features of narcolepsy making it difficult to analyze with classical statistics. Stochastic gradient boosting, a supervised learning model with built-in feature selection, results in high performances in testing set. While cataplexy features are recognized as the most influential predictors, machine find additional features, e.g. mean rapid-eye-movement sleep latency of multiple sleep latency test contributes to classify NT1 and NT2 as confirmed by classical statistical analysis. Our results suggest ML can identify features of CH on machine scale from complex databases, thus providing ‘ideas’ and promising candidates for future diagnostic classifications.
- 13 July 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-11
Open AccessExploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning
Narcolepsy is a rare life-long disease that exists in two forms, narcolepsy type-1 (NT1) or type-2 (NT2), but only NT1 is accepted as clearly defined entity. Both types of narcolepsies belong to the group of central hypersomnias (CH), a spectrum of poorly defined diseases with excessive daytime sleepiness as a core feature. Due to the considerable overlap of symptoms and the rarity of the diseases, it is difficult to identify distinct phenotypes of CH. Machine learning (ML) can help to identify phenotypes as it learns to recognize clinical features invisible for humans. Here we apply ML to data from the huge European Narcolepsy Network (EU-NN) that contains hundreds of mixed features of narcolepsy making it difficult to analyze with classical statistics. Stochastic gradient boosting, a supervised learning model with built-in feature selection, results in high performances in testing set. While cataplexy features are recognized as the most influential predictors, machine find additional features, e.g. mean rapid-eye-movement sleep latency of multiple sleep latency test contributes to classify NT1 and NT2 as confirmed by classical statistical analysis. Our results suggest ML can identify features of CH on machine scale from complex databases, thus providing ‘ideas’ and promising candidates for future diagnostic classifications.
- Open Access
- 8 March 2018
- Published by Wiley in Journal of Sleep Research
- Vol. 28 (2) , e12679
Automatic artefact detection in single‐channel sleep EEG recordings
Summary: Quantitative electroencephalogram analysis (e.g. spectral analysis) has become an important tool in sleep research and sleep medicine. However, reliable results are only obtained if artefacts are removed or excluded. Artefact detection is often performed manually during sleep stage scoring, which is time consuming and prevents application to large datasets. We aimed to test the performance of mostly simple algorithms of artefact detection in polysomnographic recordings, derive optimal parameters and test their generalization capacity. We implemented 14 different artefact detection methods, optimized parameters for derivation C3A2 using receiver operator characteristic curves of 32 recordings, and validated them on 21 recordings of healthy participants and 10 recordings of patients (different laboratory) and considered the methods as generalizable. We also compared average power density spectra with artefacts excluded based on algorithms and expert scoring. Analyses were performed retrospectively. We could reliably identify artefact contaminated epochs in sleep electroencephalogram recordings of two laboratories (healthy participants and patients) reaching good sensitivity (specificity 0.9) with most algorithms. The best performance was obtained using fixed thresholds of the electroencephalogram slope, high‐frequency power (25–90 Hz or 45–90 Hz) and residuals of adaptive autoregressive models. Artefacts in electroencephalogram data can be reliably excluded by simple algorithms with good performance, and average electroencephalogram power density spectra with artefact exclusion based on algorithms and manual scoring are very similar in the frequency range relevant for most applications in sleep research and sleep medicine, allowing application to large datasets as needed to address questions related to genetics, epidemiology or precision medicine.
- 8 March 2018
- Published by Wiley in Journal of Sleep Research
- Vol. 28 (2) , e12679
Open AccessAutomatic artefact detection in single‐channel sleep EEG recordings
Summary: Quantitative electroencephalogram analysis (e.g. spectral analysis) has become an important tool in sleep research and sleep medicine. However, reliable results are only obtained if artefacts are removed or excluded. Artefact detection is often performed manually during sleep stage scoring, which is time consuming and prevents application to large datasets. We aimed to test the performance of mostly simple algorithms of artefact detection in polysomnographic recordings, derive optimal parameters and test their generalization capacity. We implemented 14 different artefact detection methods, optimized parameters for derivation C3A2 using receiver operator characteristic curves of 32 recordings, and validated them on 21 recordings of healthy participants and 10 recordings of patients (different laboratory) and considered the methods as generalizable. We also compared average power density spectra with artefacts excluded based on algorithms and expert scoring. Analyses were performed retrospectively. We could reliably identify artefact contaminated epochs in sleep electroencephalogram recordings of two laboratories (healthy participants and patients) reaching good sensitivity (specificity 0.9) with most algorithms. The best performance was obtained using fixed thresholds of the electroencephalogram slope, high‐frequency power (25–90 Hz or 45–90 Hz) and residuals of adaptive autoregressive models. Artefacts in electroencephalogram data can be reliably excluded by simple algorithms with good performance, and average electroencephalogram power density spectra with artefact exclusion based on algorithms and manual scoring are very similar in the frequency range relevant for most applications in sleep research and sleep medicine, allowing application to large datasets as needed to address questions related to genetics, epidemiology or precision medicine.
- 11 January 2018
- Published by Georg Thieme Verlag KG in Pharmacopsychiatry
- Vol. 51 (04) , 144-147
Sertindole: EEG Analysis, Tolerability, and Clinical Efficacy
Introduction One of the common side effects of antipsychotic drugs is excessive sedation. The treatment with antipsychotics often manifests as an increase in slow wave activity in electroencephalography (EEG). The aim of this study was to analyze EEG recordings of patients treated with a non-sedative antipsychotic drug sertindole with regard to its adverse effects and clinical efficacy. Patients and methods EEG recordings of 45 patients (27 females, mean age 30.1±8.7 years) with schizophrenia were analyzed. EEG recordings were categorized based on abnormalities severity. The clinical efficacy was rated on the Clinical Global Impression Scale. Results Abnormalities from mild to moderate were found in 29% of the group. Clinical improvement was observed in 80% of patients. Sedation/daytime sleepiness was present in 7% of patients. Other side effects were prolongation of QTc (11%, severe 4%), insomnia (9%), extrapyramidal symptoms (7%), and heart palpitations (2%). Conclusions Patients treated with sertindole do not show side effects similar to those found during treatment with other antipsychotic drugs. Increased slow wave activity in EEG and sedation were absent in the majority of the investigated patients.
- 11 January 2018
- Published by Georg Thieme Verlag KG in Pharmacopsychiatry
- Vol. 51 (04) , 144-147
Sertindole: EEG Analysis, Tolerability, and Clinical Efficacy
Introduction One of the common side effects of antipsychotic drugs is excessive sedation. The treatment with antipsychotics often manifests as an increase in slow wave activity in electroencephalography (EEG). The aim of this study was to analyze EEG recordings of patients treated with a non-sedative antipsychotic drug sertindole with regard to its adverse effects and clinical efficacy. Patients and methods EEG recordings of 45 patients (27 females, mean age 30.1±8.7 years) with schizophrenia were analyzed. EEG recordings were categorized based on abnormalities severity. The clinical efficacy was rated on the Clinical Global Impression Scale. Results Abnormalities from mild to moderate were found in 29% of the group. Clinical improvement was observed in 80% of patients. Sedation/daytime sleepiness was present in 7% of patients. Other side effects were prolongation of QTc (11%, severe 4%), insomnia (9%), extrapyramidal symptoms (7%), and heart palpitations (2%). Conclusions Patients treated with sertindole do not show side effects similar to those found during treatment with other antipsychotic drugs. Increased slow wave activity in EEG and sedation were absent in the majority of the investigated patients.
- 30 September 2017
- Published by Care Comm in Česká a slovenská neurologie a neurochirurgie
- Vol. 80/113 (5) , 561-563
Smoking Prevalence in Group of Central-European Patients with Narcolepsy-cataplexy, Narcolepsy without Cataplexy and Idiopathic Hypersomnia
- 30 September 2017
- Published by Care Comm in Česká a slovenská neurologie a neurochirurgie
- Vol. 80/113 (5) , 561-563
Smoking Prevalence in Group of Central-European Patients with Narcolepsy-cataplexy, Narcolepsy without Cataplexy and Idiopathic Hypersomnia
- Top Cited PapersOpen Access
- 9 August 2017
- Published by Springer Nature in Current Psychiatry Reports
- Vol. 19 (9) , 1-7
Effects of Antidepressants on Sleep
Purpose of Review The aim of this review article was to summarize recent publications on effects of antidepressants on sleep and to show that these effects not only depend on the kind of antidepressant drugs but are also related to the dose, the time of drug administration, and the duration of the treatment. Recent Findings Complaints of disrupted sleep are very common in patients suffering from depression, and they are listed among diagnostic criteria for this disorder. Moreover, midnocturnal insomnia is the most frequent residual symptom of depression. Thus, all antidepressants should normalize sleep. However, at least in short-term treatment, many antidepressants with so-called activating effects (e.g. fluoxetine, venlafaxine) may disrupt sleep, while others with sedative properties (e.g., doxepin, mirtazapine, trazodone) rapidly improve sleep, but may cause problems in long-term treatment due to oversedation.For sleep-promoting action, the best effects can frequently be achieved with a very low dose, administered early enough before bedtime and importantly, always as a part of more complex interventions based on the cognitive-behavioral protocol to treat insomnia (CBT-I). Summary For successful treatment of depression, it is necessary to understand the effects of antidepressants on sleep. Each physician should also be aware that some antidepressants may worsen or induce primary sleep disorders like restless legs syndrome, sleep bruxism, REM sleep behavior disorder, nightmares, and sleep apnea, which may result from an antidepressant-induced weight gain.
- 9 August 2017
- Published by Springer Nature in Current Psychiatry Reports
- Vol. 19 (9) , 1-7
Top Cited PapersOpen AccessEffects of Antidepressants on Sleep
Purpose of Review The aim of this review article was to summarize recent publications on effects of antidepressants on sleep and to show that these effects not only depend on the kind of antidepressant drugs but are also related to the dose, the time of drug administration, and the duration of the treatment. Recent Findings Complaints of disrupted sleep are very common in patients suffering from depression, and they are listed among diagnostic criteria for this disorder. Moreover, midnocturnal insomnia is the most frequent residual symptom of depression. Thus, all antidepressants should normalize sleep. However, at least in short-term treatment, many antidepressants with so-called activating effects (e.g. fluoxetine, venlafaxine) may disrupt sleep, while others with sedative properties (e.g., doxepin, mirtazapine, trazodone) rapidly improve sleep, but may cause problems in long-term treatment due to oversedation.For sleep-promoting action, the best effects can frequently be achieved with a very low dose, administered early enough before bedtime and importantly, always as a part of more complex interventions based on the cognitive-behavioral protocol to treat insomnia (CBT-I). Summary For successful treatment of depression, it is necessary to understand the effects of antidepressants on sleep. Each physician should also be aware that some antidepressants may worsen or induce primary sleep disorders like restless legs syndrome, sleep bruxism, REM sleep behavior disorder, nightmares, and sleep apnea, which may result from an antidepressant-induced weight gain.
- Open Access
- 1 January 2017
- Published by Termedia Sp. z.o.o. in Postępy Psychiatrii i Neurologii
- Vol. 26 (4) , 255-269
Non-paraneoplastic variant of limbic encephalitis – case report
Purpose : Limbic encephalitis (LE) is a rare but necessary condition to consider when experiencing cognitive disorders, seizures, and psychiatric disorders. Case description : This article presents a case of a 28-year-old patient with uncontrolled disease history, with systemic symptoms of...
- 1 January 2017
- Published by Termedia Sp. z.o.o. in Postępy Psychiatrii i Neurologii
- Vol. 26 (4) , 255-269
Open AccessNon-paraneoplastic variant of limbic encephalitis – case report
Purpose : Limbic encephalitis (LE) is a rare but necessary condition to consider when experiencing cognitive disorders, seizures, and psychiatric disorders. Case description : This article presents a case of a 28-year-old patient with uncontrolled disease history, with systemic symptoms of...
- Open Access
- 1 January 2017
- Published by Termedia Sp. z.o.o. in Postępy Psychiatrii i Neurologii
- Vol. 26 (3) , 194-202
REM behaviour sleep disorder – case study
Purpose : REM behaviour sleep disorder (RBD) is a parasomnia and involves sudden movements and/or vocalizations that reflect the dream content. This disorder is a common symptom of neurodegenerative diseases or their prodromal symptom. Until recently, clonazepam was the most commonly used...
- 1 January 2017
- Published by Termedia Sp. z.o.o. in Postępy Psychiatrii i Neurologii
- Vol. 26 (3) , 194-202
Open AccessREM behaviour sleep disorder – case study
Purpose : REM behaviour sleep disorder (RBD) is a parasomnia and involves sudden movements and/or vocalizations that reflect the dream content. This disorder is a common symptom of neurodegenerative diseases or their prodromal symptom. Until recently, clonazepam was the most commonly used...